课题基金 / 基金详情

Lipid Metabolism in Fat Cells

Lipid Metabolism in Fat Cells
脂肪细胞中的脂质代谢
批准号:
7754894
负责人:
WEN GUO
金额:
$27.91万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-06-01 至 2010-12-31

项目摘要

项目成果

WEN GUO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Obesity is a major health problem that predisposes to type 2 diabetes and other serious conditions. A more complete understanding of how fat synthesis is regulated in adipocytes is critical to guide rational development of new approaches for treating obesity and its complications. In the last grant period, we demonstrated that medium-chain fatty acids (octanoate) stimulate beta-oxidation and inhibit triglyceride synthesis in adipocytes, mimicking some of the metabolic effects of fasting. Analogous anti-lipogenic effects have been found in adipocytes treated with TNFalpha. We demonstrated that the three stressors,fasting in vivo, octanoate, and TNFalpha in vitro, induce many of the same cellular responses. These include increased generation of reactive oxidative species (ROS), activation of MAP-kinases (MARK) and AMP- activated protein kinase (AMPK), and decreased expression of the nuclear transcription factor PPARgamma and associated lipogenic genes. In light of these findings, we plan to use these three stressorsto manipulate lipogenesis in adipocytes to dissect mechanisms of regulation. We hypothesize that critical signals (ROS or ROS-independent) are generatedas a result of increased beta-oxidation.These signaling molecules activate stress-responsive kinases, which inactivate PPARgamma,attenuating expression of genes necessary for fat synthesis. To test this hypothesis, we propose the following specific aims: (1) to determine whether ROS is crucial for regulation of lipogenesis; (2) to test if changes in beta-oxidation generate critical signals that cause inactivation of PPARgamma; and (3) to determine if PPARgamma is the point at which signals converge that control stress-induced anti-lipogenic effects, what is the mechanism of PPARgamma inactivation, and which metabolic genes are most sensitive to the stress manipulation. Each aim will be addressed with comprehensive and integratedapplication of cell biology and molecular biology in combination with metabolic and biochemical approaches, using culture murine and human adipocytes as well as rodent models. Together, these studies will provide new insights into the stress-induced regulation of lipogenesis in adipocytes, a potentially important avenue for modulating energy balance.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1677/joe.0.1740267
发表时间: 2002-08
期刊: The Journal of endocrinology
影响因子: --
作者: [Y-L Wang-Fisher;J. Han;W. Guo]
通讯作者: Y-L Wang-Fisher;J. Han;W. Guo
Modulation of adipocyte lipogenesis by octanoate: involvement of reactive oxygen species.
通过辛酸盐调节脂肪细胞脂肪生成:活性氧的参与。
DOI: 10.1186/1743-7075-3-30
发表时间: 2006-07-27
期刊: NUTRITION & METABOLISM
影响因子: 4.5
作者: [Guo, Wen, Xie, Weisheng, Han, Jianrong]
通讯作者: Han, Jianrong
AAV-mediated administration of myostatin pro-peptide mutant in adult Ldlr null mice reduces diet-induced hepatosteatosis and arteriosclerosis.
在成年 Ldlr 缺失小鼠中,AAV 介导的肌生成抑制素前肽突变体可减少饮食诱导的肝脂肪变性和动脉硬化。
DOI: 10.1371/journal.pone.0071017
发表时间: 2013
期刊: PloS one
影响因子: 3.7
作者: [Guo,Wen, Wong,Siu, Bhasin,Shalender]
通讯作者: Bhasin,Shalender
Metabolic partitioning of endogenous fatty acid in adipocytes.
脂肪细胞内源性脂肪酸的代谢分配。
DOI: 10.1038/oby.2003.121
发表时间: 2003
期刊: Obesity research.
影响因子: --
作者: [Wang,Tong, Zang,Yan, Ling,Wenhua, Corkey,BarbaraE, Guo,Wen]
通讯作者: Guo,Wen
Healthy Aging and Myostatin Antagonsits
  • 批准号:
    8108812
  • 项目类别:
  • 资助金额:
    $20.79万
  • 财政年份:
    2011
  • 负责人:
    WEN GUO
  • 依托单位:
Healthy Aging and Myostatin Antagonsits
  • 批准号:
    8247690
  • 项目类别:
  • 资助金额:
    $17.32万
  • 财政年份:
    2011
  • 负责人:
    WEN GUO
  • 依托单位:
Lipid Metabolism in Fat Cells
  • 批准号:
    7566015
  • 项目类别:
  • 资助金额:
    $28.19万
  • 财政年份:
    2000
  • 负责人:
    WEN GUO
  • 依托单位:
LIPID METABOLISM IN FAT CELLS
  • 批准号:
    6635345
  • 项目类别:
  • 资助金额:
    $19.69万
  • 财政年份:
    2000
  • 负责人:
    WEN GUO
  • 依托单位:
海外基金